The Promise of Autologous Fibroblast Technology
-
Fibroblast cells are responsible for the production of collagen—a protein that gives skin its strength and elasticity—and other extracellular matrix proteins, and play a critical role in wound healing.
-
Autologous fibroblast cells are an individual’s own fibroblast cells and are recognized by the body’s immune system as “self”.
-
Potential applications for autologous fibroblasts extend beyond the current aesthetic indication into unmet medical needs such as restrictive burn scarring, acne scarring and vocal cord scarring.
Scientific Rigor
Aging Off Biotech’s proprietary, autologous fibroblast technology platform has broad market potential. Through this platform, the company plans to develop products for medical and aesthetic applications that address unmet medical needs.
The Company’s commitment to scientific rigor is demonstrated by:
-
Extensive clinical trials of this autologous cellular product
for use in improving the appearance of moderate to severe nasolabial fold wrinkles in adults
-
Robust intellectual property, with 5 patents and 15 patents in other countries
-
State-of-the-art manufacturing facilities licensed by the FDA
-
Research and development collaborations with Institutes and Universities
-
Exclusive Channel Collaboration with other corporations
